Vi capsular polysaccharide vaccine

Vi capsular polysaccharide vaccine
Vaccine description
Target	Typhoid
Vaccine type	Polysaccharide
Clinical data
Trade names	Typherix, Typhim VI
AHFS/Drugs.com	Multum Consumer Information
Routes of; administration	intramuscular injection, subcutaneous injection[clarification needed]
ATC code	J07AP03 (WHO) ;
Legal status
Legal status	US: ℞-only;
Identifiers
CAS Number	1704529-13-4 ;
ChemSpider	none;
KEGG	D12923;
	(what is this?) (verify)

The Vi capsular polysaccharide vaccine (or ViCPS) is a typhoid vaccine recommended by the World Health Organization for the prevention of typhoid (another is Ty21a). The vaccine was first licensed in the US in 1994 and is made from the purified Vi capsular polysaccharide from the Ty2 Salmonella Typhi strain; it is a subunit vaccine.